Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -38.491% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: CCC1CCCCN1C(=O)CSc1nnc(-c2cccc(Cl)c2)o1
b: CCn1c(CNc2ccc(Cl)cc2)nnc1SCc1ccc(Cl)cc1
c: S=C(NCc1cccnc1)c1ccccc1
Answer: a. CCC1CCCCN1C(=O)CSc1nnc(-c2cccc(Cl)c2)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1CCCCN1C(=O)CSc1nnc(-c2cccc(Cl)c2)o1
CCC1CCCCN1C(=O)CSc1nnc(-c2cccc(Cl)c2)o1
2-[[5-(3-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-1-(2-ethylpiperidin-1-yl)ethanone